Multifaceted anticancer activity of BH3 mimetics: Current evidence and future prospects
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference118 articles.
1. The Bcl-2 apoptotic switch in cancer development and therapy;Adams;Oncogene,2007
2. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
3. BH3 mimetics to improve cancer therapy; mechanisms and examples;Zhang;Drug Resist. Updat.,2007
4. An inhibitor of Bcl-2 family proteins induces regression of solid tumours;Oltersdorf;Nature,2005
5. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death;Wei;Science,2001
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Maximizing Anticancer Response with MPS1 and CENPE Inhibition Alongside Apoptosis Induction;Pharmaceutics;2023-12-29
2. Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects;European Journal of Medicinal Chemistry;2023-12
3. The novel small molecule BH3 mimetic nobiletin synergizes with vorinostat to induce apoptosis and autophagy in small cell lung cancer;Biochemical Pharmacology;2023-10
4. Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells;International Journal of Molecular Sciences;2023-05-22
5. Involvement of necroptosis in the selective toxicity of the natural compound (±) gossypol on squamous skin cancer cells in vitro;Archives of Toxicology;2023-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3